• Protein A/G Magnetic Beads: Practical Workflow Guide

  2026-09-24

  Protein A/G Magnetic Beads capture IgG antibodies from complex samples to support antibody purification, immunoprecipitation, co-IP, and Ch-IP workflows. Use them for research applications where the antibody’s Fc binding is suitable; they are not intended for diagnostic or medical use, and assay-specific conditions should be validated by the researcher.

• Forsythoside E for Reliable Macrophage Assays

  2026-09-23

  A scenario-driven guide to using Forsythoside E (SKU N2883) in macrophage viability and immunometabolic experiments. Review its reported PKM2 mechanism, concentration range, solubility, workflow controls, and practical criteria for selecting a research-grade source.

• Realgar, Ornithine, and Astrocyte Glycolysis

  2026-09-23

  A 2025 Advanced Science study defines a liver–brain mechanism for realgar-induced CNS toxicity: hepatic OTC inhibition increases ornithine, while arsenic and ornithine converge on astrocytic ZBTB7A to suppress glycolysis. Its combination of conditional animal models, astrocyte experiments, single-cell transcriptomics, metabolomics, and behavioral analysis provides a mechanistic framework for studying metabolic drivers of neurotoxicity.

• Dabigatran for Thromboembolism: AF Evidence and Context

  2026-09-22

  The 2015 review by Enriquez and colleagues synthesizes how dabigatran, the first widely introduced direct oral thrombin inhibitor, changed prevention and treatment of thromboembolic disease. Its practical contribution is an integrated interpretation of efficacy, pharmacokinetics, renal handling, bleeding management, and the distinction between anticoagulation for stroke prevention and rhythm-directed atrial fibrillation treatment.

• How LNP Entrapment Impairs Endosomal Escape

  2026-09-22

  This study shows that lipid nanoparticle delivery depends not only on cellular uptake but also on where nanoparticles accumulate within the endolysosomal pathway. Peripheral endosome entrapment restricts trafficking and cytosolic release, whereas sustained transport toward the perinuclear lysosomal region is associated with stronger transgene expression.

• Bestatin Stimulates Endothelial Invasion in Fibrin

  2026-09-21

  The 2003 reference study showed that Bestatin can enhance, rather than suppress, microvascular endothelial cell invasion and capillary-like tube formation in a fibrin matrix. Its dose-dependent and matrix-dependent effects challenge a simple anti-angiogenic interpretation and suggest that aminopeptidases other than CD13 may contribute to endothelial remodeling in fibrin-rich environments.

• Arachidonic Acid as a Dietary Vaccine Adjuvant

  2026-09-21

  The reference study shows that dietary arachidonic acid can accelerate and strengthen rabies vaccine-induced humoral immunity in mice and human volunteers. Its mechanistic contribution is a link between lymph-node lipid metabolism, prostaglandin I2 signaling, costimulation, and B-cell activation, while also defining important boundaries for translating findings to α-Linolenic Acid research.

• MoCul4–MoKmt1 Control Rice Blast Virulence

  2026-09-20

  A 2026 study identifies the Cullin4 subunit MoCul4 as an important regulator of MoKmt1-mediated H3K9 trimethylation in Magnaporthe oryzae. Loss of either factor impaired fungal growth, development, heterochromatin-associated gene silencing, and pathogenicity, linking an E3 ubiquitin-ligase component to epigenetic control of rice blast biology.

• SERCA2–CaN/FoxO1/FABP4 Axis in Atherosclerosis

  2026-09-19

  A 2025 British Journal of Pharmacology study identifies the calcineurin/FoxO1/FABP4 pathway as a mechanistic link between SERCA2 dysfunction, abnormal fatty acid handling, macrophage foam cell formation, and atherosclerosis. Its combination of SERCA2 C674S knock-in mice, metabolomics, macrophage assays, pharmacological inhibition, and partial FABP4 deficiency provides a framework for evaluating FABP4-directed interventions.

• Angiotensin 1/2 (2-7) Research Workflow

  2026-09-18

  Build controlled cardiovascular and receptor-binding assays with a high-purity Angiotensin 1/2 (2-7) peptide. This workflow connects vasoconstriction and aldosterone release stimulation studies with a carefully bounded, exploratory SARS-CoV-2 spike–receptor binding application.

• DAMGO for µ-Opioid Receptor Signaling

  2026-09-18

  DAMGO gives researchers a selective way to separate µ-opioid receptor activation from the broader behavioral effects of opioid exposure. This article translates its receptor-proximal activity into reproducible cell, tissue, and pain-circuit workflows, with practical guidance for studying analgesia, mechanical hypersensitivity, and tolerance.

• Demethyleneberberine: Reliable Cell Assay Workflows

  2026-09-17

  This scenario-based guide shows how Demethyleneberberine (SKU N2087) can be integrated into cell viability, inflammation, proliferation, and cytotoxicity workflows. It covers solvent controls, concentration selection, orthogonal endpoints, interpretation limits, and practical criteria for choosing a well-documented research compound.

• Substrate Stiffness and LAMB1–FAK–MEK1/2 Dentinogenesis

  2026-09-17

  Bai and colleagues show that substrate stiffness is an instructive regulator of odontoblast-like cell behavior, not merely a scaffold property. Their experiments connect improved cell spreading and dentinogenic differentiation to a LAMB1–FAK–MEK1/2 mechanotransduction axis, providing a mechanistic framework for reparative dentin engineering.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-09-16

  A 2025 study found that naturally occurring angiotensin fragments can increase SARS-CoV-2 spike binding to AXL and, for angiotensin IV, to ACE2 and NRP1. Its systematic peptide-truncation and tyrosine-modification strategy connects renin-angiotensin signaling pathway chemistry with viral receptor biology, while also defining important limits for interpretation.

• Sumatriptan: From Receptor Biology to Translation

  2026-09-16

  Sumatriptan is best understood not only as an established migraine therapy, but also as a tractable 5-HT1 receptor agonist for studying the intersection of serotonergic signaling, CGRP release, neurogenic inflammation, cytokine regulation, and nitric oxide biology. This article translates the mechanistic evidence into practical experimental strategy while defining the limits of repurposing claims.

8831 records 5/589 page Previous Next 12345 下5页 Last page